Nucleix Ltd.
Clinical trials sponsored by Nucleix Ltd., explained in plain language.
-
Simple urine test could replace scopes for bladder cancer detection
Diagnosis Recruiting nowThis study is testing a new urine test called Bladder EpiCheck to see how well it finds bladder cancer in people aged 45 and older who have blood in their urine. About 800 participants will provide a urine sample and then undergo standard cystoscopy (a camera exam of the bladder)…
Sponsor: Nucleix Ltd. • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC
-
Scientists seek urine samples to perfect bladder cancer detection
Knowledge-focused Recruiting nowThis study collects urine samples from 1,000 people who may have bladder cancer or are being monitored for it. The goal is to help improve the Bladder EpiCheck test, which looks for signs of cancer in urine. Participants provide one urine sample and share basic health information…
Sponsor: Nucleix Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC